- Home
- AMAT vs JNJ Comparison
AMAT vs JNJ Comparison
Compare AMAT & JNJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMAT | JNJ |
|---|---|---|
| Founded | 1967 | 1886 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 239.4B | 589.2B |
| IPO Year | 1994 | 2003 |
Fundamental Metrics
Financial Performance| Metric | AMAT | JNJ |
|---|---|---|
| Price | $345.77 | $243.28 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 28 | 18 |
| Target Price | ★ $334.57 | $228.56 |
| AVG Volume (30 Days) | 6.4M | ★ 7.3M |
| Earning Date | 05-14-2026 | 04-21-2026 |
| Dividend Yield | 0.57% | ★ 2.16% |
| EPS Growth | 0.58 | ★ 90.50 |
| EPS | 2.54 | ★ 11.03 |
| Revenue | ★ $14,608,000,000.00 | N/A |
| Revenue This Year | $13.01 | $6.63 |
| Revenue Next Year | $19.66 | $7.23 |
| P/E Ratio | $128.52 | ★ $21.81 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $123.74 | $141.50 |
| 52 Week High | $395.95 | $251.71 |
Technical Indicators
Market Signals| Indicator | AMAT | JNJ |
|---|---|---|
| Relative Strength Index (RSI) | 50.43 | 58.04 |
| Support Level | $311.07 | $201.37 |
| Resistance Level | $395.95 | $251.71 |
| Average True Range (ATR) | 13.39 | 4.22 |
| MACD | -5.95 | -1.52 |
| Stochastic Oscillator | 34.02 | 49.08 |
Price Performance
Historical ComparisonAbout AMAT Applied Materials Inc.
Applied Materials is the largest semiconductor wafer fabrication equipment manufacturer in the world. It has a broad portfolio spanning nearly every corner of the WFE ecosystem. Applied Materials holds leading market share in deposition, which entails the layering of new materials on semiconductor wafers. It is more exposed to general-purpose logic chips made at integrated device manufacturers and foundries. It counts the largest chipmakers in the world as customers, including TSMC, Intel, and Samsung.
About JNJ Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.